Active, not recruiting
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
NCT03380962
- Conditions
- Antibody-mediated Rejection, Behavior, Chronic Disease, +19 more
- Locations
-
- Norko Ammerman Los Angeles, California, United States